| The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in … BC Dickerson, A Bakkour, DH Salat, E Feczko, J Pacheco, DN Greve, ... Cerebral cortex 19 (3), 497-510, 2008 | 1247 | 2008 |
| Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis KA Celone, VD Calhoun, BC Dickerson, A Atri, EF Chua, SL Miller, ... Journal of Neuroscience 26 (40), 10222-10231, 2006 | 884 | 2006 |
| The Alzheimer’s Disease Clinical Spectrum: Diagnosis and Management A Atri Medical Clinics 103 (2), 263-293, 2019 | 813 | 2019 |
| Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS) S Weintraub, L Besser, HH Dodge, M Teylan, S Ferris, FC Goldstein, ... Alzheimer disease and associated disorders 32 (1), 10, 2018 | 547 | 2018 |
| A single-pool model for intracellular calcium oscillations and waves in the Xenopus laevis oocyte A Atri, J Amundson, D Clapham, J Sneyd Biophysical Journal 65 (4), 1727-1739, 1993 | 434 | 1993 |
| Aducanumab: appropriate use recommendations J Cummings, P Aisen, LG Apostolova, A Atri, S Salloway, M Weiner The journal of prevention of Alzheimer's disease 8 (4), 398-410, 2021 | 373 | 2021 |
| Long-term course and effectiveness of combination therapy in Alzheimer’s disease A Atri, LW Shaughnessy, JJ Locascio, JH Growdon Alzheimer disease and associated disorders 22 (3), 209, 2008 | 363 | 2008 |
| Current and Future Treatments in Alzheimer's Disease A Atri Seminars in neurology 39 (02), 227-240, 2019 | 322 | 2019 |
| Aducanumab produced a clinically meaningful benefit in association with amyloid lowering J Cummings, P Aisen, C Lemere, A Atri, M Sabbagh, S Salloway Alzheimer's research & therapy 13 (1), 1-3, 2021 | 248 | 2021 |
| Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders YH El-Hayek, RE Wiley, CP Khoury, RP Daya, C Ballard, AR Evans, ... Journal of Alzheimer's Disease, 1-19, 2019 | 236 | 2019 |
| A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery SD Shirk, MB Mitchell, LW Shaughnessy, JC Sherman, JJ Locascio, ... Alzheimer's research & therapy 3 (6), 32, 2011 | 213 | 2011 |
| Thyroid nodule shape and prediction of malignancy EK Alexander, E Marqusee, J Orcutt, CB Benson, MC Frates, PM Doubilet, ... Thyroid 14 (11), 953-958, 2004 | 212 | 2004 |
| Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task. A Atri, S Sherman, KA Norman, BA Kirchhoff, MM Nicolas, MD Greicius, ... Behavioral neuroscience 118 (1), 223, 2004 | 210 | 2004 |
| Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis JL Liss, S Seleri Assunção, J Cummings, A Atri, DS Geldmacher, ... Journal of Internal Medicine 290 (2), 310-334, 2021 | 201 | 2021 |
| In the Information Age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers’ education needs, barriers, and … K Peterson, H Hahn, AJ Lee, CA Madison, A Atri BMC geriatrics 16 (1), 164, 2016 | 178 | 2016 |
| Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with Alzheimer disease: three randomized clinical trials A Atri, L Frölich, C Ballard, PN Tariot, JL Molinuevo, N Boneva, K Windfeld, ... Jama 319 (2), 130-142, 2018 | 175 | 2018 |
| An overview of longitudinal data analysis methods for neurological research JJ Locascio, A Atri Dementia and geriatric cognitive disorders extra 1 (1), 330-357, 2011 | 170 | 2011 |
| Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy A Atri, JL Molinuevo, O Lemming, Y Wirth, I Pulte, D Wilkinson Alzheimer's research & therapy 5 (1), 6, 2013 | 168 | 2013 |
| Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans K Schon, A Atri, ME Hasselmo, MD Tricarico, ML LoPresti, CE Stern Journal of Neuroscience 25 (40), 9112-9123, 2005 | 159 | 2005 |
| Aducanumab: Appropriate Use Recommendations Update J Cummings, GD Rabinovici, A Atri, P Aisen, LG Apostolova, S Hendrix, ... The Journal of Prevention of Alzheimer's Disease 9 (2), 221-230, 2022 | 156 | 2022 |
Jeffrey CummingsCleveland Clinic Lou Ruvo Center for Brain Health在 ccf.org 的电子邮件经过验证
